Expanding access to PARP inhibitors in prostate cancer treatment March 14, 2023 Last month, Myriad attended the 2023 ASCO Genitourinary Cancers Symposium (ASCO GU) to connect with researchers and doctors around emergent and controversial a... Continue Reading